HOXA9 and urinary bladder carcinoma: Methylation of HOXA9 has been reported previously in oral cavity cancer[6], and methylation and loss of expression of HOXA9 reported in breast[4,7,8], lung[9], ovarian[10] and bladder cancer[11], whereas HOXA9 is well known to act as an oncogene in leukemia[5].